1:24 New Strategies for Cytopenia Management in MDS July 18, 2021 • AML Content Hub @UP11558193 of the University of Leipzig, Germany, discusses #cytopenia #management for patients with #MDS.
1:26 Promising New Enzyme Replacement Therapy for Late-Onset Pompe Disease July 17, 2021 • Pompe Disease Content Hub Priya Kishnani, MD, from @DukeMedSchool, discusses the use of #avalglucosidase alfa in late-onset #PompeDisease.
25:58 Pain Management in Pompe Disease July 17, 2021 • Pompe Disease Content Hub Jonathan Rajan, MBChB, from the Salford Royal Foundation Trust, discusses #pain in patients with #PompeDisease.
A Tool for Personalized Immunogenicity Risk Assessment July 17, 2021 • Pompe Disease Content Hub Anne S. De Groot, MD, of EpiVax, Inc., and the Center for Vaccines and Immunology, University of Georgia, and colleagues present a study designed to develop a #tool…
24:02 Using CRISPR to Correct GAA Mutations July 17, 2021 • Pompe Disease Content Hub Kris Saha, PhD, of @UWMadEngr, discusses #CRISPR and #genomeediting in #PompeDisease.
5:15 Safety and Efficacy of New Enzyme Replacement Therapy for Pompe Disease July 17, 2021 • Pompe Disease Content Hub @HaniKushlaf, of @UCNeuroPMR, discusses the #safety and #efficacy of #avalglucosidase alfa in #PompeDisease.
38:43 Nutrition and Diet Considerations in Patients With Pompe Disease July 17, 2021 • Pompe Disease Content Hub Gisela Wilcox, BMedSc, MBBS, MD, of Salford Royal NHS Foundation Trust, discusses diet and nutritional considerations in Pompe disease.
44:48 An Overview of Pompe Disease July 17, 2021 • Pompe Disease Content Hub Stephanie Austin, MS, MA, of @DukeMedSchool, provides an overview of #PompeDisease, including #GeneticCounseling availability.
59:05 Diagnosis, Management, and Research Related to Pompe Disease July 17, 2021 • Pompe Disease Content Hub Mark Tarnopolsky, MD, PhD, of @McMasterU, discusses #PompeDisease #management and #research.
2:15 Newborn Screening: Communication With Parents July 17, 2021 • Pompe Disease Content Hub Dawn Laney, MS, CGC, CCRC, of the Emory Genetic Clinical Trials Center, discusses #communication with parents regarding #newbornscreening.
1:22 The Immunological Impact of TP53 in Patients With MDS July 16, 2021 • AML Content Hub @ShahramKordasti, of @KingsCollegeLon, discusses the #immunological impact of TP53 mutations on #MDS #prognosis.
3:56 The Impact of Genetics on Treatment for Patients With MDS July 16, 2021 • AML Content Hub Valeria Santini, MD, University of Florence, Italy, discusses the #genomiclandscape of #MDS.
